NEW YORK, Dec. 4 – Proteomics and functional genomics company Large Scale Biology Corporation said Tuesday it had exercised an option to expand its deal with Plant Bioscience of Norwich, UK, to include all higher plants.
In June, LSBC of Vacaville, Calif., licensed viral-derived gene silencing and overexpression technology from Plant Bioscience, an intellectual property management company that manages emerging technologies from academic institutions.
At the time of the original deal, LSBC said it would use the technology in conjunction with its Geneware plant viral vectors on a limited range of plants.
The expanded deal will now include the application of the technology for commercially relevant monocots in addition to dicots.
The expanded use of the PBL license "allows LSBC's patented Geneware functional genomics technology to include monocots as well as dicots as we introduce gene sequences rapidly into mature plants in just a matter of days, not months,” Guy della-Cioppa, LSBC vice president of business development, said in a statement.
“We then study overexpression gain-of-function phenotypes or gene silencing loss-of-function phenotypes,” he added.
Financial terms of the deal were not disclosed.